tiprankstipranks
Advertisement
Advertisement

CHRS Stock Latest News

Coherus Biosciences Announces 2026 Stockholder Meeting Results
Company AnnouncementsCoherus Biosciences Announces 2026 Stockholder Meeting Results
14d ago
8K
CHRS
Coherus Biosciences Signals Momentum in Earnings Call
PremiumCompany Announcements
Coherus Biosciences Signals Momentum in Earnings Call
27d ago
CHRS
Coherus Biosciences Signals Confident Oncology Earnings Outlook
PremiumCompany Announcements
Coherus Biosciences Signals Confident Oncology Earnings Outlook
1M ago
CHRS
Analyst Reiterates Buy on Loqtorzi Momentum and Temporary Q1 Headwinds; $7 Price Target Maintained
PremiumRatings
Analyst Reiterates Buy on Loqtorzi Momentum and Temporary Q1 Headwinds; $7 Price Target Maintained
1M ago
CHRS
Coherus Oncology reports Q1 EPS (28c), consensus (26c)
PremiumThe Fly
Coherus Oncology reports Q1 EPS (28c), consensus (26c)
1M ago
CHRS
Guggenheim starts Coherus with Buy on anti-tumor potential
PremiumThe FlyGuggenheim starts Coherus with Buy on anti-tumor potential
1M ago
CHRS
Coherus Oncology initiated with a Buy at Guggenheim
Premium
The Fly
Coherus Oncology initiated with a Buy at Guggenheim
1M ago
CHRS
CHRS Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
CHRS Earnings this Week: How Will it Perform?
2M ago
CHRS
Coherus BioSciences Charts Leaner Path After Earnings Call
PremiumCompany Announcements
Coherus BioSciences Charts Leaner Path After Earnings Call
2M ago
CHRS
Coherus BioSciences: Buy Rating Backed by LOQTORZI’s Market Leadership and Advancing Immuno-Oncology Pipeline
PremiumRatings
Coherus BioSciences: Buy Rating Backed by LOQTORZI’s Market Leadership and Advancing Immuno-Oncology Pipeline
3M ago
CHRS
Coherus: Strategic Oncology Pivot and Loqtorzi Growth Drive Buy Rating
PremiumRatings
Coherus: Strategic Oncology Pivot and Loqtorzi Growth Drive Buy Rating
3M ago
CHRS
Coherus Oncology reports Q4 EPS (34c), consensus (31c)
PremiumThe Fly
Coherus Oncology reports Q4 EPS (34c), consensus (31c)
3M ago
CHRS
Options Volatility and Implied Earnings Moves Today, March 09, 2026
PremiumMarket NewsOptions Volatility and Implied Earnings Moves Today, March 09, 2026
3M ago
DDD
HPE
CHRS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CHRS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
CHRS
Coherus Biosciences Completes $47 Million Equity Offering
Premium
Company Announcements
Coherus Biosciences Completes $47 Million Equity Offering
4M ago
8K
CHRS
Coherus Oncology 28.6M share Spot Secondary priced at $1.75
PremiumThe Fly
Coherus Oncology 28.6M share Spot Secondary priced at $1.75
4M ago
CHRS
Coherus Oncology announces common stock offering, no amount given
PremiumThe Fly
Coherus Oncology announces common stock offering, no amount given
4M ago
CHRS
Coherus Signs Clinical Supply Deal With Janssen Oncology
PremiumCompany Announcements
Coherus Signs Clinical Supply Deal With Janssen Oncology
4M ago
8K
CHRS
Coherus Biosciences Updates ATM Equity Offering Program
PremiumCompany Announcements
Coherus Biosciences Updates ATM Equity Offering Program
5M ago
8K
CHRS
Coherus Oncology initiated with an Outperform at Oppenheimer ahead of readouts
PremiumThe FlyCoherus Oncology initiated with an Outperform at Oppenheimer ahead of readouts
5M ago
CHRS
Coherus Oncology initiated with an Outperform at Oppenheimer
Premium
The Fly
Coherus Oncology initiated with an Outperform at Oppenheimer
5M ago
CHRS
Coherus Oncology announces publication highlighting CCR8 antibody tagmokitug
Premium
The Fly
Coherus Oncology announces publication highlighting CCR8 antibody tagmokitug
5M ago
CHRS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >